TEXAS INSTRUMENTS INC (TXN) Insider Transactions
Explore official ownership filings, with every record linked to its source.
TXN · TEXAS INSTRUMENTS INC
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-29Filed 2026-10-30 | KIRK RONALDDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The option became exercisable in four equal annual installments beginning on January 26, 2018. References: F2 | M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 6,065D | 0 | Direct | Form 4 ↗0000097476-26-000178 |
| 2026-10-29Filed 2026-10-30 | KIRK RONALDDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The option became exercisable in four equal annual installments beginning on January 26, 2018. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 6,065D | 310.39 | Direct | Form 4 ↗0000097476-26-000178 |
| 2026-10-29Filed 2026-10-30 | KIRK RONALDDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The option became exercisable in four equal annual installments beginning on January 26, 2018. References: | M Exercise / conversionCommon Stock · Non-derivative | 6,065A | 79.26 | Direct | Form 4 ↗0000097476-26-000178 |
| 2026-10-27Filed 2026-10-29 | SANCHEZ ROBERT EDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 26, 2018. References: F3 | M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 6,065D | 0 | Direct | Form 4 ↗0000097476-26-000172 |
| 2026-10-27Filed 2026-10-29 | SANCHEZ ROBERT EDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 26, 2018. References: F2 | S Sale (market/private)Common Stock · Non-derivative | 477D | 303.07 | Direct | Form 4 ↗0000097476-26-000172 |
| 2026-10-27Filed 2026-10-29 | SANCHEZ ROBERT EDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 26, 2018. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 5,588D | 302.14 | Direct | Form 4 ↗0000097476-26-000172 |
| 2026-10-27Filed 2026-10-29 | SANCHEZ ROBERT EDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 26, 2018. References: | M Exercise / conversionCommon Stock · Non-derivative | 6,065A | 79.26 | Direct | Form 4 ↗0000097476-26-000172 |
| 2026-10-27Filed 2026-10-29 | PATSLEY PAMELA HDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The option became exercisable in four equal annual installments beginning on January 25, 2020. References: F2 | M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 4,532D | 0 | Direct | Form 4 ↗0000097476-26-000174 |
| 2026-10-27Filed 2026-10-29 | PATSLEY PAMELA HDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The option became exercisable in four equal annual installments beginning on January 25, 2020. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 4,532D | 301.56 | Direct | Form 4 ↗0000097476-26-000174 |
| 2026-10-27Filed 2026-10-29 | PATSLEY PAMELA HDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The option became exercisable in four equal annual installments beginning on January 25, 2020. References: | M Exercise / conversionCommon Stock · Non-derivative | 4,532A | 104.41 | Direct | Form 4 ↗0000097476-26-000174 |
| 2026-10-27Filed 2026-10-29 | CLARK JANET FDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 25, 2019. References: F3 | M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 4,306D | 0 | Direct | Form 4 ↗0000097476-26-000176 |
| 2026-10-27Filed 2026-10-29 | CLARK JANET FDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 25, 2019. References: F2 | S Sale (market/private)Common Stock · Non-derivative | 350D | 303.17 | Direct | Form 4 ↗0000097476-26-000176 |
| 2026-10-27Filed 2026-10-29 | CLARK JANET FDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 25, 2019. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 3,956D | 302.4 | Direct | Form 4 ↗0000097476-26-000176 |
| 2026-10-27Filed 2026-10-29 | CLARK JANET FDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The option became exercisable in four equal annual installments beginning on January 25, 2019. References: | M Exercise / conversionCommon Stock · Non-derivative | 4,306A | 110.15 | Direct | Form 4 ↗0000097476-26-000176 |
| 2026-09-18Filed 2026-09-21 | FARMER CURTIS CDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Security converts to common stock on a one-for-one basis. F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan. References: F1, F2 | A Award / grantStock Units · Derivative | 106.53A | 258.14 | Direct | Form 4 ↗0000097476-26-000161 |
| 2026-09-18Filed 2026-09-21 | PATSLEY PAMELA HDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Security converts to common stock on a one-for-one basis. F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan. References: F1, F2 | A Award / grantStock Units · Derivative | 106.53A | 258.14 | Direct | Form 4 ↗0000097476-26-000158 |
| 2026-08-27Filed 2026-08-31 | Abraham TsedeniyaOfficer · Sr. Vice PresidentFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018. References: F3 | M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative | 1,365D | 0 | Direct | Form 4 ↗0000097476-26-000156 |
| 2026-08-27Filed 2026-08-31 | Abraham TsedeniyaOfficer · Sr. Vice PresidentFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018. References: F2 | S Sale (market/private)Common Stock · Non-derivative | 592D | 264.96 | Direct | Form 4 ↗0000097476-26-000156 |
| 2026-08-27Filed 2026-08-31 | Abraham TsedeniyaOfficer · Sr. Vice PresidentFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 6,408D | 264.6 | Direct | Form 4 ↗0000097476-26-000156 |
| 2026-08-27Filed 2026-08-31 | Abraham TsedeniyaOfficer · Sr. Vice PresidentFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018. References: | M Exercise / conversionCommon Stock · Non-derivative | 1,365A | 79.26 | Direct | Form 4 ↗0000097476-26-000156 |
| 2026-07-24Filed 2026-07-31 | Knecht Julie C.Officer · VP & Chief Accounting OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Award of restricted stock units pursuant to 2024 Long-Term Incentive Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 7,154A | 0 | Direct | Form 4 ↗0000097476-26-000154 |
| 2026-06-19Filed 2026-06-22 | FARMER CURTIS CDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Security converts to common stock on a one-for-one basis. F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan. References: F1, F2 | A Award / grantStock Units · Derivative | 85.18A | 322.86 | Direct | Form 4 ↗0000097476-26-000145 |
| 2026-06-19Filed 2026-06-22 | PATSLEY PAMELA HDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Security converts to common stock on a one-for-one basis. F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan. References: F1, F2 | A Award / grantStock Units · Derivative | 85.18A | 322.86 | Direct | Form 4 ↗0000097476-26-000144 |
| 2026-05-28Filed 2026-05-29 | Craighead Martin SDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. References: | S Sale (market/private)Common Stock · Non-derivative | 357D | 321.0069 | Direct | Form 4 ↗0001319699-26-000004 |
| 2026-05-28Filed 2026-05-29 | Craighead Martin SDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 9,643D | 320.4075 | Direct | Form 4 ↗0001319699-26-000004 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.